Cellectar Biosciences, Inc. — Director's Dealing 2018

Dec 1, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cellectar Biosciences, Inc. (CLRB)
CIK: 0001279704
Period of Report: 2018-11-30

Reporting Person: CARUSO JAMES V (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-11-30	Common Stock, par value $0.00001 per share	P	1000	$2.282	Acquired	22354	Direct